Tradestie Institutional Equity Comparison Engine

GCTK vs CISS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CISS Overall Edge

CISS Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to C3is Inc. Common Stock (CISS) driven by superior Growth & Margin, Momentum & Technical while GCTK counters with relative strength in Options & Structure. Fundamentally, GCTK trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CISS at N/M Forward P/E and 24.6% operating margin (+249.0% YoY). In options structure, GCTK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CISS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
GCTK N/M vs CISS N/M Fwd P/E
Growth & Margin Winner CISS
Op Margin 0.0% vs 24.6% ยท YoY +0.0% vs +249.0%
Momentum & Technical Winner CISS
1Y -81.0% vs -25.4% ยท 52W Pos 16% vs 20%
Options & Structure Winner GCTK
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
GCTK NASDAQ
GlucoTrack, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.39
-32.2% 1D
Market Cap $2.4M
1M Return -15.24%
1Y Return -80.96%
Forward P/E N/M
Unified AI Score
36.9 / 100 SELL
Tech 5.0 Fund 40.0 Flow 50.0 Mom 70.0
CISS NASDAQ
C3is Inc. Common Stock
Deep Sea Foreign Transportation Of Freight
$1.23
+4.24% 1D
Market Cap $991,199
1M Return +135.23%
1Y Return -25.45%
Forward P/E N/M
Unified AI Score
33.6 / 100 SELL
Tech 5.0 Fund 29.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GCTK -80.96% CISS -25.45% Spread: +5.26 pp (CISS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period GCTK Revenue CISS Revenue GCTK Op. Margin CISS Op. Margin Margin Edge
FY2015 $0M N/A -3251.7% N/A GCTK
FY2016 $0M N/A -924.6% N/A GCTK
FY2017 $0M N/A 1794.2% N/A GCTK
FY2018 $0M N/A -15035.4% N/A GCTK
FY2019 $0M N/A 1685.6% N/A GCTK
FY2023 N/A $30M N/A 36.3% CISS
FY2024 N/A $40M N/A 23.8% CISS
FY2025 N/A $30M N/A 3.9% CISS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GCTK (2) vs CISS (5)
Institutional Metric GCTK CISS Criterion Row Winner
Market Capitalization Scale $2.4M $991,199 Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +249.0% Higher Growth CISS
Operating Margin (TTM) Profitability 0.0% 24.6% Higher Margin CISS
Net Profit Margin Profitability 0.0% 27.4% Higher Margin CISS
Return on Equity (ROE) Capital Efficiency -620.6% 17.1% Higher ROE CISS
52-Week Range Position Momentum 16% ($0โ€“$8) 20% ($0โ€“$6) Stronger Trend CISS
Beta / 30D Volatility Risk Regime 1.08ฮฒ ยท 1052% Vol 11.91ฮฒ ยท 1054% Vol Lower Realized Risk GCTK
Unified Institutional Score Composite Signal 36.9 / 100 (SELL) 33.6 / 100 (SELL) Higher Composite GCTK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GCTK vs CISS Buy Guide
GCTK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GCTK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CISS BREAKDOWN
64d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CISS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GCTK nor CISS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.